✦ LIBER ✦

Efficacy of lenalidomide in a patient with myelodysplastic syndrome with isolated del(5q) and JAK2V617F mutation

✍ Scribed by Meritxell Nomdedeu; Margherita Maffioli; Xavier Calvo; Alejandra Martínez-Trillos; Tycho Baumann; Marina Díaz-Beyá; Josep-Lluís Aguilar; María Rozman; Dolors Costa; Jordi Esteve; Francisco Cervantes; Dolors Colomer; Benet Nomdedeu

Book ID: 113773476
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 175 KB
Volume: 35
Category: Article
ISSN: 0145-2126
DOI: 10.1016/j.leukres.2011.06.008

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

JAK2 V617F mutation is uncommon in patie

JAK2 V617F mutation is uncommon in patients with the 3q21q26 syndrome

✍ Pei Lin; Rajyalakshmi Luthra; Roberto H. Nussenzveig; L. Jeffrey Medeiros 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 509 KB

Hematologic and cytogenetic response to

Hematologic and cytogenetic response to lenalidomide monotherapy in acute myeloid leukemia arising from JAK2V617F positive, del(5)(q13q33) myelodysplastic syndrome

✍ Mesa, R A; Tefferi, A; Li, C-Yang; Steensma, D P 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 119 KB

The lack of association between JAK2 V61

The lack of association between JAK2 V617F mutation and myelodysplastic syndrome with or without myelofibrosis

✍ Yip, S-F; So, C-C; Chan, Ay-Y; Liu, Hs-Y; Wan, Ts-K; Chan, L-C 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 51 KB

The JAK2 V617F mutation identifies a sub

The JAK2 V617F mutation identifies a subgroup of MDS patients with isolated deletion 5q and a proliferative bone marrow

✍ Ingram, W; Lea, N C; Cervera, J; Germing, U; Fenaux, P; Cassinat, B; Kiladjian, 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 190 KB

Isolated erythrocytosis in V617F negativ

Isolated erythrocytosis in V617F negative patients with JAK2 exon 12 mutations: Report of a new mutation

✍ Martina Bernardi; Marco Ruggeri; Elena Albiero; Domenico Madeo; Francesco Rodegh 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB 👁 1 views

JAK2V617F mutation and myeloproliferativ

JAK2V617F mutation and myeloproliferative malignancy in a patient with Type 1 Gaucher disease

✍ Bryn D. Webb; Neal J. Weinreb; Anthony C. Botti; Brian M. Kirmse; Manisha Balwan 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 131 KB